PARSIPPANY, N.J., May 18, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc., a leading specialty global pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference on Wednesday, May 30, 2012 at 4:00PM Eastern Time at the Waldorf-Astoria Hotel in New York, New York.
HAWTHORNE, N.Y.--(BUSINESS WIRE)--May 18, 2012 - Taro Pharmaceutical Industries Ltd., announced today that it will release its financial results for the quarter ended March 31, 2012 after market close on Thursday, May 24, 2012.
MONT-SAINT-GUIBERT, Belgium, May 18, 2012/PRNewswire/ --The Belgian biotechnology company, Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces that the final results of its Phase II clinical trial of C3BS-CQR-1 is will be presented at the late breaking clinical trial session at the European Society of Cardiology 2012 Heart Failure Congress in Belgrade, Serbia taking place on May 19-22.
COLUMBUS, Ohio--(BUSINESS WIRE)--May 18, 2012 - Ohio's bioscience industry is in growth mode. Proof (and jobs) will be on display at BioOhio's May 23 Biomedical & Pharma Career Fair in Columbus.
BETHLEHEM, Pa., May 18, 2012 /PRNewswire/ -- Digestive Care, Inc. (DCI), announced that the company has received U.S. Food and Drug Administration (FDA) approval of its New Drug Application (NDA) for PERTZYE, indicated for the treatment of Exocrine Pancreatic Insufficiency (EPI) due to cystic fibrosis (CF) or other conditions.
PHILADELPHIA, May 18, 2012/PRNewswire/ -- Migraine Meter, a free mobile app to help patients manage and monitor their migraines launched today by Health Union, LLC.
It looks to be a relatively quiet American Society of Clinical Oncology (ASCO) meeting this year, judging by Wall Street’s sedate reaction to Wednesday evening’s abstract dump, an event that usually sends stocks jumping while analysts and investors scramble to keep up.
PARSIPPANY, N.J., May 18, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Norethindrone Acetate/Ethinyl Estradiol and Ethinyl Estradiol and Ferrous Fumarate Tablets,1 mg/0.01 mg and 0.01 mg and 75 mg.
NEW YORK, May 18, 2012 /PRNewswire/ -- Intellect Neurosciences, Inc. announces that Dr. Daniel G. Chain, the company's chairman and CEO, will be presenting at the Seventh Annual Neurotech Investing and Partnering Conference.
PITTSBURGH and NEW YORK, May 18, 2012 /PRNewswire/ -- The Drug Store News Group, the Pharmacist Society and Mylan Inc., one of the world's leading generics and specialty pharmaceutical companies, are pleased to announce an exclusive sponsorship to expand membership opportunities at PharmacistSociety.com – an online forum that supports and enhances professional networks for U.S.-based retail pharmacists, professional organizations and pharmacy companies.
WASHINGTON--(BUSINESS WIRE)--May 18, 2012 - Building on its recent testimony to the FDA on modernizing clinical trials, the Association of Clinical Research Organizations (ACRO) has released a new video exhorting the FDA to demonstrate “bold leadership” to help make the drug development process less expensive, faster and more productive.
ATLANTA, May 18, 2012 /PRNewswire/ -- UCB, Inc., a leading biopharmaceutical company dedicated to the research and development of treatments for severe central nervous system and immunological disorders, is marking Digestive Disease Week (DDW) 2012 in San Diego by reinforcing its commitment to improving the lives of patients with Crohn's disease. UCB will present scientific data at this year's DDW meeting.
MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--May 18, 2012 - Medgenics, Inc., the developer of the novel Biopump technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that Andrew L. Pearlman, Ph.D., the Company's President and CEO, will present a corporate overview at the 11th Annual Israeli Life Sciences Industry Biomed 2011 Conference taking place at the David Intercontinental Hotel in Tel Aviv, Israel from May 21-23, 2012.
TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--May 18, 2012 - Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that an abstract reporting new data from the BiovaxID Phase II mantle cell lymphoma clinical trial conducted by the U.S. National Cancer Institute (NCI) is now available on-line with the significance of these results to be presented by the NCI at the 2012 American Society of Clinical Oncology Annual Meeting (ASCO 2012).
INDIANAPOLIS--(BUSINESS WIRE)--May 18, 2012 - Novo Nordisk, a world leader in diabetes care, announced today that it has expanded its motorsports initiatives to include an official partnership with INDYCAR.
NEEDHAM, Mass.--(BUSINESS WIRE)--May 18, 2012 - Celldex Therapeutics, Inc. will host a conference call at 4:30 P.M. Eastern Time on Wednesday, May 23, 2012 to announce interim, topline results of the Phase 2b EMERGE study of CDX-011 in patients with advanced breast cancer.
STAMFORD, Conn., May 18, 2012 /PRNewswire/ -- Purdue Pharma L.P. will present an analysis of data from completed clinical trials for Butrans (buprenorphine) Transdermal System CIII at the American Pain Society's (APS) 31st Annual Scientific Meeting.
LUND, Sweden & PARIS--(BUSINESS WIRE)--May 18, 2012 -Active Biotech and Ipsen will present tasquinimod (TASQ), their prostate cancer drug candidate, at the scientific conference “2012 ASCO Annual Meeting” to be held in Chicago (USA) on 1-5 June 2012.
WORCESTER, Mass. and TORONTO, May 18, 2012 /PRNewswire/ -- Generex Biotechnology Corporation announced today that additional members have joined the Scientific Advisory Board (SAB) of its wholly-owned subsidiary, Antigen Express, Inc., for the company's AE37 breast cancer vaccine.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 18, 2012 - InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that CEO Frank Reynolds is scheduled to appear on KXAN-TV's Austin News Today Weekend on Saturday, May 19th at 7:20am CDT in Austin, TX.
NEW YORK--(BUSINESS WIRE)--May 18, 2012 - Forest Laboratories, Inc. and Almirall, S.A. today announced that they will present aclidinium-related data in 1 poster discussion session and 3 poster presentations at the American Thoracic Society (ATS) International Conference scheduled May 18 - 23 in San Francisco, CA.
VIENNA, Va.--(BUSINESS WIRE)--May 18, 2012 - The following letter was provided to shareholders by CEL-SCI Corporation for today's annual shareholder meeting:
MORRISTOWN, N.J., May 18, 2012 /PRNewswire/ -- Actavis Group, an international generic pharmaceuticals company, today announced that it received US FDA approval of Ropinirole Extended-Release Tablets, 2mg, 4mg, 6mg, 8mg and 12mg, a generic equivalent to GlaxoSmithKline's Requip XL.
NEW YORK--(BUSINESS WIRE)--May 18, 2012 - New York Biotechnology Association (NYBA), the voice of New York State's bioscience industry, today announced that the 2012 honorees of the Association's annual leadership awards will be the leaders of Regeneron Pharmaceuticals, New York's largest biotechnology company: Dr. Leonard Schleifer, MD, PhD, founder, president and CEO, and Dr. George Yancopoulos, MD, PhD, founding scientist, president, Regeneron Laboratories and Chief Scientific Officer.
RARITAN, N.J., May 18, 2012 /PRNewswire/ -- Data related to ZYTIGA (abiraterone acetate) clinical studies have been selected for presentation at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO).
NEW YORK, May 18, 2012 /PRNewswire/ -- The American Society of Hypertension (ASH) opens its 27th Annual Scientific Meeting on Saturday, May 19, 2012 at the Hilton in New York City.
MARLBOROUGH, Mass.--(BUSINESS WIRE)--May 18, 2012 - Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that chairman and CEO Gary Rabin will be presenting at the World Stem Cells and Regenerative Medicine Conference, May 21-23, in London.
SAN DIEGO, May 18, 2012 /PRNewswire/ -- Receptos Inc. today announced that company personnel will deliver a scientific podium presentation about RPC1063 at the Digestive Disease Week (DDW) annual meeting at 9 a.m. PDT on Sunday, May 20, 2012 at the San Diego Convention Center in San Diego, California.
SAN DIEGO--(BUSINESS WIRE)--May 18, 2012 - Santarus, Inc. today announced that safety and efficacy data from a Phase III, double-blind, multicenter, placebo-controlled 12 month extended use study with the investigational drug UCERIS (budesonide) 6 mg tablets (previously referred to as budesonide MMX) will be featured in four poster presentations at the Digestive Disease Week (DDW) Meeting being held at the San Diego Convention Center on May 19 – 22, 2012.
NEW YORK--(BUSINESS WIRE)--May 18, 2012 - Pfizer Inc. announced today the results of studies on Lyrica (pregabalin) capsules CV presented at the American Pain Society Annual Meeting in Honolulu.
HYDERABAD, India--(BUSINESS WIRE)--May 18, 2012 - Dr. Reddy's Laboratories announced today that it has launched CLOPIDOGREL TABLETS, USP 75 mg & 300 mg, a bioequivalent generic version of PLAVIX, in the U.S. market on May 18, 2012.
BILLERICA, Mass.--(BUSINESS WIRE)--May 18, 2012 - Bruker Corporation announced today that it will host its Inaugural Analyst Day on Friday, June 1st, from 8:30 a.m. to 11:30 a.m. Eastern Daylight Time, at the InterContinental New York Barclay Hotel, 111 East 48th Street, in New York City.
RALEIGH, N.C.--(BUSINESS WIRE)--May 18, 2012 - Salix Pharmaceuticals, Ltd. today announced that numerous presentations and educational activities related to the investigation of several of the Company's products or relevant disease states are scheduled to take place during Digestive Disease Week DDW 2012.
NEW YORK & PARIS--(BUSINESS WIRE)--May 18, 2012 - Bionest Partners, a premier strategy and management consulting firm for the life science industries, and a recognized leader in personalized medicine (PM) strategy consulting, announces the publication of an article in a recent issue of Nature Reviews Drug Discovery (NRDD).
WOBURN, Mass. & TOKYO--(BUSINESS WIRE)--May 18, 2012 - ArQule, Inc. (Nasdaq: ARQL) and Daiichi Sankyo, Co., Ltd. (TSE 4568) today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer (NSCLC).
|
